-
- 抗原 See all CD55 抗体
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
抗原表位
- AA 101-150
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CD55 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA
- 特异性
- CD55 Antibody detects endogenous levels of total CD55 protein.
- 纯化方法
- Immunoaffinity purified
- 免疫原
-
Synthetic peptide from human CD55 (aa101-150).
Type of Immunogen: Synthetic peptide - 亚型
- IgG
- Top Product
- Discover our top product CD55 Primary Antibody
-
-
- 应用备注
- Approved: Peptide-ELISA (1:20000), WB (1:500 - 1:1000)
- 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS (without Mg2+, Ca2+), pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C for up to 1 year.
- 有效期
- 12 months
-
-
Slt2 Is Required to Activate ER-Stress-Protective Mechanisms through TORC1 Inhibition and Hexosamine Pathway Activation." in: Journal of fungi (Basel, Switzerland), Vol. 8, Issue 2, (2022) (PubMed).
: "
-
Slt2 Is Required to Activate ER-Stress-Protective Mechanisms through TORC1 Inhibition and Hexosamine Pathway Activation." in: Journal of fungi (Basel, Switzerland), Vol. 8, Issue 2, (2022) (PubMed).
-
- 抗原
- CD55 (Complement Decay-Accelerating Factor (CD55))
- 别名
- CD55 (CD55 产品)
- 别名
- CR antibody, CROM antibody, DAF antibody, TC antibody, Daf antibody, Daf-GPI antibody, Daf1 antibody, GPI-DAF antibody, CD55 molecule (Cromer blood group) antibody, CD55 molecule, decay accelerating factor for complement antibody, CD55 antibody, Cd55 antibody
- 背景
-
Name/Gene ID: CD55
Synonyms: CD55, CD55 antigen, Decay-accelerating factor, TC, CR, CROM, DAF - 基因ID
- 1604
- UniProt
- P08174
- 途径
- Complement System, Regulation of Leukocyte Mediated Immunity
-